Sort   by:  
 Page size 
UnknownGM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.
Not available
S-EPMC7470718 | biostudies-literature
UnknownC reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.
Not available
S-EPMC10314034 | biostudies-literature
UnknownLenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Not available
S-EPMC8635458 | biostudies-literature
UnknownEfficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.
Not available
S-EPMC11581693 | biostudies-literature
Sort   by:  
 Page size